Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 442-600-9 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Two subacute toxicity studies of HiTEC 7134 via the oral route with ratsaare available.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 120 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
Additional information
Two oral subacute toxicity studies of HiTEC 7134 with rats are available, which fulfils the legal requirements for this endpoint. According to REACH legislation one short-term (28 days) repeated dose toxicity is sufficient, provided that it is performed with the most appropriate route of administration. Performing a repeated-dose inhalation study would not be relevant for this specific test material due to its physical-chemical properties. The generation of vapors or aerosols is highly complex, or unfeasible, the log Kow is above 6.4, indicating that the substance is highly lipophilic and viscous, and the vapor pressure is very low, 0.00002 Pa. Overall, conduction of a repeated-dose inhalation study for this test material may be deemed superfluous.
The first study is a 28 -day oral study was performed in accordance with the OECD Guideline 407. H7134 was administered by gavage to groups of five male and five female Alpk: APfSD (Wistar-derived) rats for 28 consecutive days in the following doses: 0, 15, 150 or 250 mg/kg bw/day. Administration of 150 or 250 mg/kg bw H7134, resulted in decreased body weights and minor changes in clinical chemical parameters, as well as organ weights. However, there was no indication of major functional changes or severe organ damage at dose levels up to and including 250 mg H7134/kg bw. The NOAEL for this study was 15 mg/kg bw.
An OECD 421 study titled “Reproductive/developmental toxicity screening test of H7134 in rats by oral gavage” (Zmarowski A, 2012) was performed that had a NOEAL of 120 mg/kg bw/day. Additional measurements particularly affecting clinical biochemistry were completed during this study so that it was similar to an OECD 422 study without the sensory reactivity to stimuli, assessment of grip strength, and other activity assessments. No toxicologically relevant effects were observed up to the highest dose level tested (120 mg/kg). The intial concentrations used were 0. 15, 60, and 250 mg/kg bw/day. However, the Group 4 animals, that were initially exposed to 250 mg/kg, had significantly reduced body weights, body weight gains, absolute and relative food consumption and adverse clinical signs were seen beginning after 4 days of treatment. After treatment was lowered to 120 mg/kg from Day 9 onwards, the condition of the animals improved substantially. While the body weights and body weight gains remained lower for these animals (except for body weight gains during post-coitum and lactation) through the treatment duration, this was not considered adverse since the body weight gains were substantially higher than controls when re-calculated from the time the dose level was lowered. There were several changes noted in clinical biochemistry parameters at 120 mg/kg bw/day, however these were not accompanied by any relevant changes in organ weights or macroscopic findings, and remained within the normal range of values available. Furthermore, increases were not observed in several endpoints that would be indicative of renal or hepatic toxicity. Furthermore, there were no toxicologically relevant effects on any of the remaining parental parameters investigated in this study (clinical observations, food consumption, clinical laboratory investigations, macroscopic examination, organ weights, and microscopic examination). Taken together, the body weight differences and the clinical biochemistry changes were not considered to be toxicologically relevant. No effects that were indictative of reproductive or developmental toxicity were seen. Therefore, the NOAEL was set at 120 mg/kg bw/day
Justification for classification or non-classification
On the basis of the aforementioned result and of the classification criteria laid down in the CLP Regulation, HiTEC7134 does not need to be classified for repeated-dose toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.